References

  1. Bouhour F, Bost M, Vial C. Maladie de Steinert. Presse Med. 2007; (36): 965-71. PubMed | Google Scholar

  2. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3? end of a transcript encoding a protein kinase family member. Cell. 1992; 68(4): 799-808. PubMed | Google Scholar

  3. Nishioka S, Filho M, Marie S, Zatz M, Costa R. Myotonic Dystrophy and Heart Disease: Behavior of Arrhythmic Events and Conduction Disturbances. Arquivos Brasileiros de Cardiologia. 2005; 84(4). PubMed | Google Scholar

  4. Mammarella A, Paradiso M, Antonini G. Natural history of cardiac involvement in myotonic dystrophy (Steinert?s disease): a 13-year follow-up study. Adv Ther. 2000; 17(5): 238-51. PubMed | Google Scholar

  5. Melacini P, Villanova C, Menegazzo E, Novelli G, Danieli G, Rizzoti G, et al. Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy. J Am Coll Cardiol. 1995; 25(1): 239-45. PubMed | Google Scholar

  6. Mathieu J, Allard P, Potvin L, Prévost C, Bégin P. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology. 1999; 52(8): 1658-62. PubMed | Google Scholar

  7. Chebel S, Ben Hamda K, Boughammoura A, Frih Ayed M, Ben Farhat MH. Anomalies cardiaques au cours de la dystrophie myotonique de Steinert. Rev Neurol. 2005; 161(10): 932-939. PubMed | Google Scholar

  8. Groh W, Lowe MR, Zipes DP. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length. J Cardiovasc Electrophysiol. 2002; 13(5): 444-8. PubMed | Google Scholar

  9. Laurent V, Pellieux S, Corcia Ph et al. Mortality in myotonic dystrophy patients in the area of prophylactic pacing devices. Int J Cardiol. 2010. Google Scholar

  10. Sovari AA, Bodine CK, Farokhi F. Caordiovascular manifestations of myotonic dystrophy-1. Cardiol Rev. 2007; 15(4): 191-194. PubMed | Google Scholar

  11. Antonini G, Guibilei F, Mammarella A, Amiccuci P, Fiorelli M, Gragnani F et al.Natural history of cardiac involvement in myotonic dystrophy: correlation with CTG repeats. Neurology. 2000; 55(8): 1207-1209. PubMed | Google Scholar

  12. Lazarus A, Varin J, Babuty D, Anselme F, Coste J, Duboc D. Long term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: A multicenter pacing study. JAm Coll Cardiol. 2002; 40(9): 1645?1652. PubMed | Google Scholar

  13. Fragola PV, Calo L, Antonini G, Morino S, Lyzi M, Nardo DD. Signal averaged electrocardiography in myotonic dystrophy. Int J Cardiol. 1995; 50(1): 61-68. PubMed | Google Scholar

  14. Babuty D, Fauchier L, Tena-Carbi D et al. Is it possible to identify infrahissian cardiac conduction abnormalities in myotonic dystrophy by non - invasive methods? Heart. 1999;82(5):634-7. Google Scholar

  15. Tokgozolu LS, Ashizuva T, Pacifico A, Armstrong RM, Epstein HF, Zoghbi WA. Cardiac involvement in a large kindred with myotonic dystrophy. J Am Med Assoc. 1995; 274(10):813-819. PubMed | Google Scholar

  16. Bouhouch R, Elhouari T, Oukerraj L, Fellat I, Zarzur J, Bennani R, Arharbi M. Management of Cardiac Involvement in Neuromuscular Diseases: Review. The Open Cardiovascular Medecine Journal. 2008; 2: 93-96. PubMed | Google Scholar

  17. Miladi MI, Charfeddine H, Feki I, Turki E, Elleuch N, Trabelsi I, Krichène S, Kammoun S, Mhiri C. les anomalies cardiaques au cours de la dystrophie myotonique de Steinert. La Revue de médecine interne. 2009; 30(7): 573?577. PubMed | Google Scholar

  18. ACC/AHA/HRS. Guidelines device based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol. 2008; 51(21):1-62. PubMed | Google Scholar

  19. De-Die-Smulders CE, Howeler CJ, Thijs C, Mirandolle JF, Anten HB, Smeets HJM et al .Age and causes of death in adult onset myotonic dystrophy. Brain. 1998; 121(8):1557-1563. PubMed | Google Scholar